[1] Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15:1765-77.
[2] Chua MLK, Wee JTS, Hui EP, Chan ATC. Nasopharyngeal carcinoma. The Lancet 2016;387:1012-24.
[3] Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424.
[4] Cheng SH, Jer-Min Jian J, Tsai SYC, Yen KL, Chu N-M, Chan K-Y, et al. Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy. International Journal of Radiation Oncology, Biology, Physics 2000;48:1323-30.
[5] Nakanishi Y, Wakisaka N, Kondo S, Endo K, Sugimoto H, Hatano M, et al. Progression of understanding for the role of Epstein-Barr virus and management of nasopharyngeal carcinoma. Cancer and Metastasis Reviews 2017;36:435-47.
[6] Schmitz SU, Grote P, Herrmann BG. Mechanisms of long noncoding RNA function in development and disease. Cell Mol Life Sci 2016;73:2491-509.
[7] Xudong L, Yan L, Xi Y, Xiaoguang W, Xiaoguang H. Long noncoding RNA H19 regulates EZH2 expression by interacting with miR-630 and promotes cell invasion in nasopharyngeal carcinoma. Biochem Biophys Res Commun 2016.
[8] Gao C, Lu W, Lou W, Wang L, Xu Q. Long noncoding RNA HOXC13-AS positively affects cell proliferation and invasion in nasopharyngeal carcinoma via modulating miR-383-3p/HMGA2 axis. J Cell Physiol 2019;234:12809-20.
[9] Zheng Z-Q, Li Z-X, Zhou G-Q, Lin L, Zhang L-L, Lv J-W, et al. Long Noncoding RNA FAM225A Promotes Nasopharyngeal Carcinoma Tumorigenesis and Metastasis by Acting as ceRNA to Sponge miR-590-3p/miR-1275 and Upregulate ITGB3. Cancer Res 2019;79:4612-26.
[10] Lan X, Liu X. LncRNA SNHG1 functions as a ceRNA to antagonize the effect of miR-145a-5p on the down-regulation of NUAK1 in nasopharyngeal carcinoma cell. J Cell Mol Med 2019;23:2351-61.
[11] Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 2011;146:353-8.
[12] Karreth FA, Pandolfi PP. ceRNA cross-talk in cancer: when ce-bling rivalries go awry. Cancer Discov 2013;3:1113-21.
[13] Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC bioinformatics 2008;9:559.
[14] Liu R, Zhang W, Liu ZQ, Zhou HH. Associating transcriptional modules with colon cancer survival through weighted gene co-expression network analysis. BMC genomics 2017;18:361.
[15] Wan Q, Tang J, Han Y, Wang D. Co-expression modules construction by WGCNA and identify potential prognostic markers of uveal melanoma. Experimental eye research 2018;166:13-20.
[16] Zhang S, Yue W, Xie Y, Liu L, Li S, Dang W, et al. The four‑microRNA signature identified by bioinformatics analysis predicts the prognosis of nasopharyngeal carcinoma patients. Oncol Rep 2019;42:1767-80.
[17] Ge Y, He Z, Xiang Y, Wang D, Yang Y, Qiu J, et al. The identification of key genes in nasopharyngeal carcinoma by bioinformatics analysis of high-throughput data. Mol Biol Rep 2019;46:2829-40.
[18] Paraskevopoulou MD, Vlachos IS, Karagkouni D, Georgakilas G, Kanellos I, Vergoulis T, et al. DIANA-LncBase v2: indexing microRNA targets on non-coding transcripts. Nucleic Acids Res 2016;44:D231-8.
[19] Chou C-H, Shrestha S, Yang C-D, Chang N-W, Lin Y-L, Liao K-W, et al. miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucleic Acids Res 2017;46:D296-D302.
[20] Langfelder P, Luo R, Oldham MC, Horvath S. Is My Network Module Preserved and Reproducible? PLoS computational biology 2011;7.
[21] Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic acids research 2015;43:e47.
[22] Zou Z, Gan S, Liu S, Li R, Huang J. Investigation of differentially expressed genes in nasopharyngeal carcinoma by integrated bioinformatics analysis. Oncol Lett 2019;18:916-26.
[23] Zhang L, MacIsaac KD, Zhou T, Huang PY, Xin C, Dobson JR, et al. Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes. Molecular cancer research : MCR 2017;15:1722-32.
[24] Therneau T. A Package for Survival Analysis in S. version 2.38. 2015.
[25] Kassambara A. Kosinski M. survminer: Drawing survival curves using “ggplot2,” 2018. URL https://CRAN R-project org/package= survminer R package version 04 2018;3.
[26] Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics : a journal of integrative biology 2012;16:284-7.
[27] TIBSHIRANI R. THE LASSO METHOD FOR VARIABLE SELECTION IN THE COX MODEL. Statistics in Medicine 1997;16:385-95.
[28] Friedman J, Hastie T, Tibshirani R. Regularization Paths for Generalized Linear Models via Coordinate Descent. J Stat Softw 2010;33:1-22.
[29] Saha-Chaudhuri P, Hapb P. survivalROC: Time-dependent ROC curve estimation from censored survival data. R Package Version 2013;1.
[30] Gordon M, Lumley T. Forestplot: advanced forest plot using ‘grid’graphics. 2017. URL https://CRAN R-project org/package= forestplot R package version 2017;1:7.
[31] Guo L-L, Song C-H, Wang P, Dai L-P, Zhang J-Y, Wang K-J. Competing endogenous RNA networks and gastric cancer. World J Gastroenterol 2015;21:11680-7.
[32] Chen J, Yang R, Zhang W, Wang Y. Candidate pathways and genes for nasopharyngeal carcinoma based on bioinformatics study. International Journal of Clinical and Experimental Pathology 2015;8:2026-32.
[33] Wang W, Wen Q, Luo J, Chu S, Chen L, Xu L, et al. Suppression Of β-catenin Nuclear Translocation By CGP57380 Decelerates Poor Progression And Potentiates Radiation-Induced Apoptosis in Nasopharyngeal Carcinoma. Theranostics 2017;7:2134-49.
[34] Sung FL, Hui EP, Tao Q, Li H, Tsui NB, Lo YM, et al. Genome-wide expression analysis using microarray identified complex signaling pathways modulated by hypoxia in nasopharyngeal carcinoma. Cancer Lett 2007;253:74-88.
[35] Li AC, Xiao WW, Wang L, Shen GZ, Xu AA, Cao YQ, et al. Risk factors and prediction-score model for distant metastasis in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy. Tumour Biol 2015;36:8349-57.
[36] Su Y, Yu QH, Wang XY, Yu LP, Wang ZF, Cao YC, et al. JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression. BMC Cancer 2017;17:477.
[37] Li H, Li X, Ge X, Jia L, Zhang Z, Fang R, et al. MiR-34b-3 and miR-449a inhibit malignant progression of nasopharyngeal carcinoma by targeting lactate dehydrogenase A. Oncotarget 2016.
[38] Ma Y, Fei L, Zhang M, Zhang W, Liu X, Wang C, et al. Lamin B2 binding to minichromosome maintenance complex component 7 promotes non-small cell lung carcinogenesis. Oncotarget 2017;8:104813-30.
[39] Maquat LE, Chilcote R, Ryan PM. Human triosephosphate isomerase cDNA and protein structure. Studies of triosephosphate isomerase deficiency in man. J Biol Chem 1985;260:3748-53.
[40] Chen T, Huang Z, Tian Y, Lin B, He R, Wang H, et al. Clinical significance and prognostic value of Triosephosphate isomerase expression in gastric cancer. Medicine (Baltimore) 2017;96:e6865.
[41] Weeks LD, Fu P, Gerson SL. Uracil-DNA glycosylase expression determines human lung cancer cell sensitivity to pemetrexed. Molecular cancer therapeutics 2013;12:2248-60.
[42] Liu N, Chen NY, Cui RX, Li WF, Li Y, Wei RR, et al. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncology 2012;13:633-41.
[43] Li Y, He Q, Wen X, Hong X, Yang X, Tang X, et al. EZH2-DNMT1-mediated epigenetic silencing of miR-142-3p promotes metastasis through targeting ZEB2 in nasopharyngeal carcinoma. Cell death and differentiation 2019;26:1089-106.
[44] Qi X, Li J, Zhou C, Lv C, Tian M. MiR-142-3p Suppresses SOCS6 Expression and Promotes Cell Proliferation in Nasopharyngeal Carcinoma. Cell Physiol Biochem 2015;36:1743-52.
[45] Vrba L, Futscher BW. Epigenetic Silencing of MORT Is an Early Event in Cancer and Is Associated with Luminal, Receptor Positive Breast Tumor Subtypes. J Breast Cancer 2017;20:198-202.
[46] Li Y-J, Yang Z, Wang Y-Y, Wang Y. Long noncoding RNA ZNF667-AS1 reduces tumor invasion and metastasis in cervical cancer by counteracting microRNA-93-3p-dependent PEG3 downregulation. Molecular oncology 2019;13:2375-92.
[47] Dong Z, Li S, Wu X, Niu Y, Liang X, Yang L, et al. Aberrant hypermethylation-mediated downregulation of antisense lncRNA ZNF667-AS1 and its sense gene ZNF667 correlate with progression and prognosis of esophageal squamous cell carcinoma. Cell Death Dis2019. p. 930.
[48] Meng W, Cui W, Zhao L, Chi W, Cao H, Wang B. Aberrant methylation and downregulation of ZNF667-AS1 and ZNF667 promote the malignant progression of laryngeal squamous cell carcinoma. J Biomed Sci2019. p. 13.
[49] Vrba L, Futscher BW. Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. F1000Research2018. p. 211.
[50] Han P, Lin Z-R, Xu L-H, Zhong Q, Zhu X-F, Liang F-Y, et al. Ribonucleotide reductase M2 subunit expression and prognostic value in nasopharyngeal carcinoma. Mol Med Rep 2015;12:401-9.
[51] Jiang JH, Jia WH, Qin HD, Liang H, Pan ZG, Zeng YX. Expression of cytochrome P450 enzymes in human nasopharyngeal carcinoma and non-cancerous nasopharynx tissue. Ai Zheng 2004;23:672-7.
[52] Christensen LL, True K, Hamilton MP, Nielsen MM, Damas ND, Damgaard CK, et al. SNHG16 is regulated by the Wnt pathway in colorectal cancer and affects genes involved in lipid metabolism. Molecular oncology 2016;10:1266-82.
[53] Zhang K, Chen J, Song H, Chen L-B. SNHG16/miR-140-5p axis promotes esophagus cancer cell proliferation, migration and EMT formation through regulating ZEB1. Oncotarget 2017;9:1028-40.
[54] Chen H, Li M, Huang P. LncRNA SNHG16 Promotes Hepatocellular Carcinoma Proliferation, Migration and Invasion by Regulating miR-186 Expression. J Cancer 2019;10:3571-81.
[55] Ma Z, Gu S, Song M, Yan C, Hui B, Ji H, et al. Long non-coding RNA SNHG17 is an unfavourable prognostic factor and promotes cell proliferation by epigenetically silencing P57 in colorectal cancer. Molecular bioSystems 2017;13:2350-61.
[56] Chen LL, He J, Qiu XT, Yu J, Wang ZM. The prognostic roles of long non-coding RNA SNHG17 in the patients with gastric cancer. European review for medical and pharmacological sciences 2019;23:1063-8.
[57] Li N, Yang G, Luo L, Ling L, Wang X, Shi L, et al. LncRNA THAP9-AS1 promotes pancreatic ductal adenocarcinoma growth and leads to a poor clinical outcome via sponging miR-484 and interacting with YAP. Clinical cancer research : an official journal of the American Association for Cancer Research 2019:clincanres.0674.2019.